BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Nuclear receptor coactivator 1 (NCOA1; SRC1); NCOA2 (SRC2); NCOA3 (SRC3; AIB1)

September 10, 2015 7:00 AM UTC

In vitro and mouse studies suggest co-stimulating NCOA1, NCOA2 and NCOA3 could help treat cancer. In multiple human cancer cell lines, a small molecule research compound that stimulated NCOA1, NCOA2 a...